Sumitomo Mitsui Trust Group, Inc. 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 06:05 am Sale | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Group, Inc. | 2,753,903 3.700% | -2,350,459 (-46.05%) | Filing |
| 2021-02-05 06:10 am Sale | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Group, Inc. | 5,104,362 7.940% | -318,856 (-5.88%) | Filing |
| 2020-12-09 06:01 am Sale | 2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Group, Inc. | 5,423,218 9.180% | -1,755,302 (-24.45%) | Filing |